Nivagen Pharmaceuticals Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
52
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
8
Nivagen Pharmaceuticals General Information
Description
Operator of a pharmaceutical company intended for developing, manufacturing, and marketing pharmaceutical products across generics and specialty drugs. The company offers development or co-development, acquisition, in-licensing, sales, and marketing of generic prescription drugs, thereby enabling Food and Drug Administration (FDA) qualified manufacturers to launch their products.
Contact Information
Website
www.nivagen.com(Operating Subsidiary)
Corporate Office
- 3050 Fite Circle
- Suite 100
- Sacramento, CA 95827
- United States
Corporate Office
- 3050 Fite Circle
- Suite 100
- Sacramento, CA 95827
- United States
Nivagen Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nivagen Pharmaceuticals Comparisons
Industry
Financing
Details
Nivagen Pharmaceuticals Competitors (2)
One of Nivagen Pharmaceuticals’s 2 competitors is Sun Pharmaceutical Industries, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Corporation | Mumbai, India | ||||
| Sandoz | Corporation | Basel, Switzerland |
Nivagen Pharmaceuticals Patents
Nivagen Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260207492-A1 | Ready-to-use sodium bicarbonate injection and methods | Pending | 23-Jan-2025 | ||
| US-20260174689-A1 | Ready-to-use morphine composition and methods | Pending | 20-Dec-2024 | ||
| US-12115187-B1 | Ready-to-use sodium phosphates injection | Active | 17-May-2024 | ||
| US-12268825-B1 | Ready-to-use sodium phosphates injection | Active | 17-May-2024 | ||
| WO-2025240934-A1 | Ready-to-use sodium phosphates injection | Pending | 17-May-2024 | A61M25/0606 |
Nivagen Pharmaceuticals Signals
Nivagen Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nivagen Pharmaceuticals FAQs
-
When was Nivagen Pharmaceuticals founded?
Nivagen Pharmaceuticals was founded in 2009.
-
Where is Nivagen Pharmaceuticals headquartered?
Nivagen Pharmaceuticals is headquartered in Sacramento, CA.
-
What is the size of Nivagen Pharmaceuticals?
Nivagen Pharmaceuticals has 52 total employees.
-
What industry is Nivagen Pharmaceuticals in?
Nivagen Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Nivagen Pharmaceuticals a private or public company?
Nivagen Pharmaceuticals is a Private company.
-
What is Nivagen Pharmaceuticals’s current revenue?
The current revenue for Nivagen Pharmaceuticals is .
-
How much funding has Nivagen Pharmaceuticals raised over time?
Nivagen Pharmaceuticals has raised $106M.
-
Who are Nivagen Pharmaceuticals’s investors?
Cadila Pharmaceuticals, Corbel Capital Partners, and Telegraph Hill Partners have invested in Nivagen Pharmaceuticals.
-
Who are Nivagen Pharmaceuticals’s competitors?
Sun Pharmaceutical Industries and Sandoz are competitors of Nivagen Pharmaceuticals.
-
When was Nivagen Pharmaceuticals acquired?
Nivagen Pharmaceuticals was acquired on 06-Jan-2026.
-
Who acquired Nivagen Pharmaceuticals?
Nivagen Pharmaceuticals was acquired by PAI Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process